Boehringer Ingelheim North America new-biz spotlight: US billings soar as Samsung and Boehringer Ingelheim change hands
Boehringer Ingelheim RetinAI Joins Forces with Boehringer Ingelheim to Advance Novel Treatments for Patients with Geographic Atrophy using Artificial Intelligence
